Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- B5704 SA 57Summary: FAAH inhibitor
- B5714 SA 47Summary: FAAH inhibitor
- B5729 GPP 78 hydrochlorideSummary: NAMPT inhibitor
- B5754 ML 298 hydrochlorideSummary: phospholipase D2 (PLD2) inhibitor
- B5799 Qc 1Summary: threonine dehydrogenase (TDH) inhibitor
- B4571 CH5138303Summary: Hsp90 inhibitor, orally available
- B7794 BMS 3094032 CitationTarget: Fatty-acid-binding proteins (FABPs)Summary: FABP4 inhibitor,potent and selective
- A8957 AUDASummary: Potent epoxide hydrolase inhibitor/PPARα activator
- B4900 Indoximod (NLG-8189)Summary: Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor
- B4928 CVT 10216Summary: reversible inhibitor of aldehyde dehydrogenase 2 (ALDH2)